NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Press Enter or click the Search button to begin your search.

Back to Results
Development of a Point of Care Technology for Military Medical Applications in Austere EnvironmentsNASA, Lawrence Livermore National Laboratory (LLNL) and the Department of Defense (DoD) share a common interest in compact medical diagnostic technologies—also known as “point of care testing” (POCT) technologies. For NASA, the need is to take care of astronauts on deep space missions. For LLNL, the focus is on technologies needed to support homeland security applications. For DoD, the need is to support warfighters in military theaters of operation, especially for prolonged field care and en route care. A recently patented technology, “Portable Medical Diagnosis Instrument” (U.S. Patent 9824870), co-invented by NASA and LLNL, is being developed further in a partnership between NASA, LLNL and Travis Air Force Base, with a focus on military applications. This instrument, the NASA-LLNL Medical Tricorder, can be used for a wide range of clinical samples including breath, saliva and blood. One component of the Tricorder is the NASA E-Nose, a carbon nanotube-based chemical sensor, integrated into a hand-held smart phone, that can detect and measure “breath biomarkers” in the gas phase of exhaled breath. The response of the NASA E-Nose is rapid, which makes it possible to detect various gas-phase substances in real time. The NASA E-Nose, with modification, can also be used for breath condensate analysis. Another component of the Tricorder is a miniaturized microfluidic analyzer, under development by LLNL, that does not require any pumps. The microfluidic analyzer can detect and measure biomarkers in liquid samples, such as blood, saliva and breath condensate. This microfluidic system requires small quantities of liquid sample and can perform analysis very rapidly (seconds to minutes), which makes it possible to detect relevant biomarkers in near real time in the field. The Clinical Investigation Facility (CIF) at Travis Air Force Base is currently conducting research with the goal to develop improved field-able technologies and procedures for the emergency response to life threatening injuries soldiers may receive in theater. This work includes experimental large animal systems and comprehensive collection of clinical specimens and physiological data. NASA and LLNL are partnering with Travis to test and further develop the Tricorder technology for high priority military applications, initially focused on lung injury models and traumatic brain injury.
Document ID
20200001155
Acquisition Source
Ames Research Center
Document Type
Poster
Authors
Loftus, David J.
(NASA Ames Research Center Moffett Field, CA, United States)
Li, Jing
(NASA Ames Research Center Moffett Field, CA, United States)
Straume, Tore
(NASA Ames Research Center Moffett Field, CA, United States)
Coleman, Matt
(Lawrence Livermore National Lab. Livermore, CA, United States)
Frank, Matthias
(Lawrence Livermore National Lab. Livermore, CA, United States)
Mukerjee, Erik
(Lawrence Livermore National Lab. Livermore, CA, United States)
Johnson, M. Austin
(David Grant USAF Medical Center Travis AFB, Fairfield, CA, United States)
Stewart, Ian
(David Grant USAF Medical Center Travis AFB, Fairfield, CA, United States)
Date Acquired
February 25, 2020
Publication Date
August 21, 2019
Subject Category
Aerospace Medicine
Report/Patent Number
ARC-E-DAA-TN72500
Report Number: ARC-E-DAA-TN72500
Meeting Information
Meeting: Military Health System Research Symposium
Location: Kissimmee, FL
Country: United States
Start Date: August 19, 2019
End Date: August 22, 2019
Sponsors: Department of Defense
Distribution Limits
Public
Copyright
Public Use Permitted.
Technical Review
NASA Technical Management
No Preview Available